{
  "parse": {
    "title": "Rs7412",
    "pageid": 1774,
    "categories": [
      {
        "sortkey": "",
        "*": "Is_a_snp"
      },
      {
        "sortkey": "",
        "*": "In_dbSNP"
      },
      {
        "sortkey": "",
        "*": "SNPs_on_chromosome_19"
      },
      {
        "sortkey": "",
        "*": "Has_genotype"
      },
      {
        "sortkey": "",
        "*": "Has_population"
      },
      {
        "sortkey": "",
        "*": "Uses_omim"
      },
      {
        "sortkey": "",
        "*": "On_chip_23andMe_v2"
      },
      {
        "sortkey": "",
        "*": "On_chip_23andMe_v3"
      },
      {
        "sortkey": "",
        "*": "On_chip_23andMe_v4"
      },
      {
        "sortkey": "",
        "*": "On_chip_23andMe_v5"
      },
      {
        "sortkey": "",
        "*": "On_chip_Ancestry_v2c"
      },
      {
        "sortkey": "",
        "*": "On_chip_Ancestry_v2d"
      },
      {
        "sortkey": "",
        "*": "On_chip_FTDNA2"
      },
      {
        "sortkey": "",
        "*": "On_chip_HumanOmni1Quad"
      },
      {
        "sortkey": "",
        "*": "On_chip_Illumina_Human_1M"
      }
    ],
    "wikitext": {
      "*": "{{Rsnum\n|rsid=7412\n|Gene=APOE\n|Chromosome=19\n|position=44908822\n|Orientation=plus\n|ReferenceAllele=C\n|MissenseAllele=T\n|GMAF=0.07392\n|Assembly=GRCh38\n|GenomeBuild=38.1\n|dbSNPBuild=141\n|geno1=(C;C)\n|geno2=(C;T)\n|geno3=(T;T)\n|Gene_s=APOE\n|StabilizedOrientation=plus\n}}{{ population diversity\n| geno1=(C;C)\n| geno2=(C;T)\n| geno3=(T;T)\n| CEU | 0.0 | 0.0 | 0.0\n| HCB | 82.0 | 18.0 | 0.0\n| JPT | 89.4 | 10.6 | 0.0\n| YRI | 83.3 | 16.7 | 0.0\n| ASW | 78.6 | 19.6 | 1.8\n| CHB | 82.0 | 18.0 | 0.0\n| CHD | 86.0 | 14.0 | 0.0\n| GIH | 92.1 | 6.9 | 1.0\n| LWK | 89.6 | 10.4 | 0.0\n| MEX | 89.3 | 10.7 | 0.0\n| MKK | 87.8 | 12.2 | 0.0\n| TSI | 90.9 | 9.1 | 0.0\n| HapMapRevision=28\n}}The ancestral allele is C. The [[rs7412]](T) allele, also known as Arg176Cys, generally indicates the presence of an Apo&#949;2 allele; see the [[ApoE]] page for a full discussion of the ApoE alleles and their association with [[Alzheimer's disease]].\n\nAnother SNP related to ApoE is [[rs429358]].\n\n{{omim\n|desc=APOE2 ISOFORMS\n|id=107741\n|rsnum=7412\n|variant=0001\n}}\n{{omim\n| id = 107741\n| variant = 0019\n| desc    = HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE2-FUKUOKA\n| rsnum   = 7412\n}}\n\n{{omim\n|desc=STROKE, ISCHEMIC\n|id=601367\n|rsnum=7412\n}}\n\n{{PMID Auto\n|PMID=20406466\n|Title=Genetic variants associated with fasting blood lipids in the U.S. population: Third National Health and Nutrition Examination Survey\n|OA=1\n}}\n{{PMID Auto\n|PMID=20429872\n|Title=Additive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and [[hypertriglyceridemia]]: results of the ICARIA genetic sub-study\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=21263195\n|Title=An APOE Haplotype Associated with Decreased ?4 Expression Increases the Risk of Late Onset Alzheimer's Disease\n}}\n\n{{PMID Auto\n|PMID=22174202\n|Title=Apolipoprotein E Gene Polymorphisms Are Strong Predictors of Inflammation and Dyslipidemia in Rheumatoid Arthritis\n}}\n\n{{PMID Auto GWAS\n|PMID=22286219\n|Trait=None\n|Title=Genome-wide association study identifies multiple loci influencing human serum metabolite levels.\n|RiskAllele=\n|Pval=3E-58\n|OR=0.7500\n|ORtxt=None\n|OA=1\n}}\n\n{{ClinVar\n|rsid=7412\n|Reversed=0\n|FwdREF=C\n|FwdALT=T\n|REF=C\n|ALT=T\n|RSPOS=45412079\n|CHROM=19\n|GMAF=0.0742\n|dbSNPBuildID=52\n|SSR=0\n|SAO=1\n|VP=0x050368000a05150537130100\n|GENEINFO=APOE:348\n|GENE_NAME=APOE\n|GENE_ID=348\n|WGT=1\n|VC=SNV\n|CLNALLE=1\n|CLNHGVS=NC_000019.9:g.45412079C>T\n|CLNORIGIN=1\n|CLNSIG=255\n|Tags=PM;PMC;S3D;SLO;NSM;REF;ASP;VLD;G5;HD;GNO;KGPhase1;KGPhase3;LSD;MTP;OM\n|CAF=0.9249; 0.07508\n|CLNACC=RCV000019428.28; RCV000019439.27; RCV000019452.30; RCV000019454.28; RCV000211178.1; RCV000346955.1\n|CLNDBN=Familial type 3 hyperlipoproteinemia; Apolipoproteinemia E1; atorvastatin response - Efficacy; not provided\n|CLNSRC=OMIM Allelic Variant; PharmGKB Clinical Annotation; UniProtKB (protein)\n|CLNSRCID=107741.0001; 107741.0009; 107741.0019; 107741.0021; 1183492249; P02649#VAR_000664\n|COMMON=1\n|Disease=Familial type 3 hyperlipoproteinemia; Apolipoproteinemia E1; atorvastatin response - Efficacy; not provided\n|CLNDSDB=MedGen:OMIM:Orphanet:SNOMED_CT; MedGen\n|CLNDSDBID=C0020479:617347:ORPHA412:398796005; CN236484; CN221809\n|CLNREVSTAT=no_criteria; exp\n}}\n\n{{PMID|15113403|OA=1\n}} Current limitations of SNP data from the public domain for studies of complex disorders: a test for ten candidate genes for obesity and osteoporosis.\n\n{{PMID|15157284|OA=1\n}} Patterns of linkage disequilibrium and haplotype distribution in disease candidate genes.\n\n{{PMID|16603077|OA=1\n}} Variation at APOE and STH loci and Alzheimer's disease.\n\n{{PMID|17356695|OA=1\n}} Variation in GYS1 interacts with exercise and gender to predict cardiovascular mortality.\n\n{{PMID|17357073|OA=1\n}} Genetic analysis of 103 candidate genes for coronary artery disease and associated phenotypes in a founder population reveals a new association between endothelin-1 and high-density lipoprotein cholesterol.\n\n{{PMID|17434289|OA=1\n}} Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association.\n\n{{PMID|17658295}} Association of ApoE genetic variants with obstructive sleep apnea in children.\n\n{{PMID|17672902|OA=1\n}} Subarachnoid hemorrhage: tests of association with apolipoprotein E and elastin genes.\n\n{{PMID|17903299|OA=1\n}} A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study.\n\n{{PMID|18034366}} Lack of replication of genetic associations with human longevity.\n\n{{PMID|18216863|OA=1\n}} Genetic determinants of basal C-reactive protein expression in Filipino systemic lupus erythematosus families.\n\n{{PMID|18254975|OA=1\n}} Physiogenomic comparison of human fat loss in response to diets restrictive of carbohydrate or fat.\n\n{{PMID|18275964|OA=1\n}} Low-density lipoprotein and high-density lipoprotein cholesterol levels in relation to genetic polymorphisms and menopausal status: the Atherosclerosis Risk in Communities (ARIC) Study.\n\n{{PMID|18378515|OA=1\n}} APOE/C1/C4/C2 hepatic control region polymorphism influences plasma apoE and LDL cholesterol levels.\n\n{{PMID|18513389|OA=1\n}} New application of intelligent agents in sporadic amyotrophic lateral sclerosis identifies unexpected specific genetic background.\n\n{{PMID|18603647|OA=1\n}} Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response.\n\n{{PMID|18823527|OA=1\n}} A genome-wide association study for late-onset Alzheimer's disease using DNA pooling.\n\n{{PMID|18974842|OA=1\n}} Gender differences in genetic risk profiles for cardiovascular disease.\n\n{{PMID|18976728|OA=1\n}} Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE.\n\n{{PMID|19001172|OA=1\n}} Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study: implication of additional loci.\n\n{{PMID|19014573|OA=1\n}} Application of two machine learning algorithms to genetic association studies in the presence of covariates.\n\n{{PMID|19058936|OA=1\n}} A polymorphism of apolipoprotein E (APOE) gene is associated with age at natural menopause in Caucasian females.\n\n{{PMID|19118814|OA=1\n}} Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease.\n\n{{PMID|19131662|OA=1\n}} A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients.\n\n{{PMID|19262956}} GAB2 gene does not modify the risk of Alzheimer's disease in Spanish APOE 4 carriers.\n\n{{PMID|19263529|OA=1\n}} Genetic risk factors in recurrent venous thromboembolism: A multilocus, population-based, prospective approach.\n\n{{PMID|19285141|OA=1\n}} Genetic determinants of target and novelty-related event-related potentials in the auditory oddball response.\n\n{{PMID|19299407|OA=1\n}} Replication of genetic associations with plasma lipoprotein traits in a multiethnic sample.\n\n{{PMID|19336475|OA=1\n}} Integrated associations of genotypes with multiple blood biomarkers linked to coronary heart disease risk.\n\n{{PMID|19377787}} Association between apolipoprotein E genotype, serum lipids, and colorectal cancer in Brazilian individuals.\n\n{{PMID|19541455}} Apolipoprotein-E gene variants associated with cardiovascular risk factors in antipsychotic recipients.\n\n{{PMID|19668339|OA=1\n}} Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease.\n\n{{PMID|19756043|OA=1\n}} A simple and efficient algorithm for genome-wide homozygosity analysis in disease.\n\n{{PMID|19787382|OA=1\n}} Introduction to the DISRUPT postprandial database: subjects, studies and methodologies.\n\n{{PMID|19802338|OA=1\n}} Genetic loci associated with plasma concentration of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, apolipoprotein A1, and Apolipoprotein B among 6382 white women in genome-wide analysis with replication.\n\n{{PMID|19913121|OA=1\n}} Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.\n\n{{PMID|19936222|OA=1\n}} Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis.\n\n{{PMID|19951432|OA=1\n}} Analysis of recently identified dyslipidemia alleles reveals two loci that contribute to risk for carotid artery disease.\n\n{{PMID|20031563}} Genetic variants associated with myocardial infarction risk factors in over 8000 individuals from five ethnic groups: The INTERHEART Genetics Study.\n\n{{PMID|20082485|OA=1\n}} Genetic variants involved in gallstone formation and capsaicin metabolism, and the risk of gallbladder cancer in Chilean women.\n\n{{PMID|20451875|OA=1\n}} Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans.\n\n{{PMID|20565774|OA=1\n}} Population based allele frequencies of disease associated polymorphisms in the Personalized Medicine Research Project.\n\n{{PMID|20663622}} A susceptible haplotype within APOE gene influences BMD and intensifies the osteoporosis risk in postmenopausal women of Northwest India.\n\n{{PMID|20682755|OA=1\n}} A pilot study of gene/gene and gene/environment interactions in Alzheimer disease.\n\n{{PMID|20832063}} Exploring genetic determinants of plasma total cholesterol levels and their predictive value in a longitudinal study.\n\n{{PMID|21215387|OA=1\n}} IQ, educational attainment, memory and plasma lipids: associations with apolipoprotein E genotype in 5995 children.\n\n{{PMID|21285406}} Low-density lipoprotein cholesterol and the risk of cancer: a mendelian randomization study.\n\n{{PMID|21379329|OA=1\n}} Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE.\n\n{{PMID|21647738|OA=1\n}} Genome-wide association with C-reactive protein levels in CLHNS: evidence for the CRP and HNF1A loci and their interaction with exposure to a pathogenic environment.\n\n{{PMID|21689001}} Association study between apolipoprotein E gene polymorphism and diabetic nephropathy in a Taiwanese population.\n\n{{PMID|21703254}} APOE haplotypes are associated with human longevity in a Central Italy population: evidence for epistasis with HP 1/2 polymorphism.\n\n{{PMID Auto GWAS\n  |PMID=23067351\n  |Trait=LDL cholesterol\n  |Title=High density GWAS for LDL cholesterol in African Americans using electronic medical records reveals a strong protective variant in APOE.\n  |RiskAllele=\n  |Pval=2E-9\n  |OR=12.30\n  |ORtxt=[8.4-16.3] mg/dL decrease\n  |OA=1\n}}\n\n{{PMID Auto\n|PMID=23050023\n|Title=Association of genetic variants influencing lipid levels with coronary artery disease in Japanese individuals\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=24291031\n|Title=Association of APOE, GCPII and MMP9 polymorphisms with common diseases and lipid levels in an older adult/elderly cohort\n}}\n\n{{PMID Auto\n|PMID=22651940\n|Title=The SIRT2 polymorphism rs10410544 and risk of Alzheimer's disease in two Caucasian case-control cohorts.\n}}\n\n{{PMID Auto\n|PMID=22710912\n|Title=TOMM40, APOE, and APOC1 in primary progressive aphasia and frontotemporal dementia.\n}}\n\n{{PMID Auto\n|PMID=22715478\n|Title=Genotypes associated with lipid metabolism contribute to differences in serum lipid profile of GH-deficient adults before and after GH replacement therapy.\n}}\n\n{{PMID Auto\n|PMID=22898894\n|Title=Pleiotropy and allelic heterogeneity in the TOMM40-APOE genomic region related to clinical and metabolic features of hepatitis C infection.\n}}\n\n{{PMID Auto\n|PMID=22922093\n|Title=Low-density lipoprotein cholesterol and risk of gallstone disease: a Mendelian randomization study and meta-analyses.\n}}\n\n{{PMID Auto\n|PMID=23430611\n|Title=Identification of a functional apolipoprotein E promoter polymorphism regulating plasma apolipoprotein E concentration.\n}}\n\n{{PMID Auto\n|PMID=23533563\n|Title=Novel risk factors for premature peripheral arterial occlusive disease in non-diabetic patients: a case-control study.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=25085564\n|Title=Influence of multiple\n|OA=1\n}}\n\n{{PMID Auto GWAS\n  |PMID=24023260\n  |Trait=Lipid traits\n  |Title=Genetic association with lipids in Filipinos: waist circumference modifies an APOA5 effect on triglyceride levels.\n  |RiskAllele=T\n  |Pval=3E-53\n  |OR=.48\n  |ORtxt=[0.42-0.54] unit decrease\n  |OA=1\n}}\n\n{{PMID Auto\n|PMID=26043189\n|Title=Genetic determinants of quantitative traits associated with cardiovascular disease risk\n}}\n\n{{PMID Auto\n|PMID=26175754\n|Title=DNA methylation and single nucleotide variants in the brain-derived neurotrophic factor (BDNF) and oxytocin receptor (OXTR) genes are associated with anxiety/depression in older women\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=26405973\n|Title=Gene environment interaction of GALNT2 and APOE gene with hypertension in the Chinese Han Population\n}}\n\n{{PMID Auto\n|PMID=26404360\n|Title=Effects of APOE rs429358, rs7412 and GSTM1/GSTT1 Polymorphism on Plasma and Erythrocyte Antioxidant Parameters and Cognition in Old Chinese Adults\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=25545672\n|Title=Apolipoprotein E gene polymorphisms in relation to chronic periodontitis, periodontopathic bacteria, and lipid levels\n}}\n\n{{PMID Auto\n|PMID=28189700\n|Title=CSF protein changes associated with hippocampal sclerosis risk gene variants highlight impact of GRN/PGRN.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=28480219\n|Title=Apolipoprotein E Genotype in Very Preterm Neonates with Intrauterine Growth Restriction: An Analysis of the German Neonatal Network Cohort.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=28512139\n|Title=A genome-wide association meta-analysis on lipoprotein(a) concentrations adjusted for apolipoprotein(a) isoforms.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=29532745\n|Title=Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosis.\n}}\n\n{{PMID Auto\n|PMID=32622117\n|Title=Trace elements and APOE polymorphisms in pregnant women and their new-borns.\n}}\n\n{{PMID Auto\n|PMID=33163038\n|Title=Lack of association between genetic variants in the 19q13.32 region and CHD risk in the Algerian population: a population-based nested case-control study.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=33204816\n|Title=Haplotype architecture of the Alzheimer's risk in the APOE region via co-skewness.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=33296721\n|Title=Quantile-specific heritability of total cholesterol and its pharmacogenetic and nutrigenetic implications.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=33437219\n|Title=Influence of CYP4F2, ApoE, and CYP2A6 gene polymorphisms on the variability of Warfarin dosage requirements and susceptibility to cardiovascular disease in Jordan.\n|OA=1\n}}\n{{on chip | 23andMe v2}}\n{{on chip | 23andMe v3}}\n{{on chip | 23andMe v4}}\n{{on chip | 23andMe v5}}\n{{on chip | Ancestry v2c}}\n{{on chip | Ancestry v2d}}\n{{on chip | FTDNA2}}\n{{on chip | HumanOmni1Quad}}\n{{on chip | Illumina Human 1M}}"
    }
  }
}